Bausch & Lomb Corp (FRA:S2L)
€ 18.1 0.3 (1.69%) Market Cap: 6.40 Bil Enterprise Value: 10.33 Bil PE Ratio: 0 PB Ratio: 1.08 GF Score: 44/100

Bausch + Lomb Corp at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2022 / 02:00PM GMT
Release Date Price: €16.8 (+3.07%)
Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst

Great. Good morning, and thank you all for joining us for the second day of the Morgan Stanley Healthcare Conference. I'm Cecilia Furlong, a medical device analyst here at Morgan Stanley. It's my pleasure to have Bausch + Lomb with us, CEO, Joe Papa; CFO, Sam Eldessouky. Before we get started, I just wanted to note our research disclosures, please see morganstanley.com/researchdisclosures. With that, Joe and Sam, thank you both for joining us.

Joseph C. Papa;Lomb Corporation;CEO;Director
Bausch

+-&

Thank you, Cecilia. Pleasure to be here.

Questions & Answers

Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst

I wanted to start just with the macro, I think, topical across everything. But for your business specifically, as you think about potential recessionary pressures, refractive, cataract, how do you think about just what transpired in prior recessions? How are you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot